用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [IPC] 包含 'H04'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页1234下页尾页34 条记录, 当前第1/4页。
公开号 公开日 申请号 申请日
1. MX2012010567A 2012/10/10 MX20120010567 2012/9/12
专利标题:USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, FOR THE PREPARATION OF A MEDICAMENT FOR ADMINISTRATION SHORTLY AFTER AMIODARONE DISCONTINUATION. 法律状态
专利权人SANOFI SA [FR];
The present invention concerns the use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for use in the prevention and/or treatment of patients with atrial fibrillation (AF) or atrial Flutter (AFL), shortly after discontinuation of a previous treatment with amiodarone.


2. EP2248536A2 2010/11/10 EP20100003702 2001/8/13
专利标题:Topical Aminolevulinic acid-photodynamic therapy for acne vulgaris 法律状态
Light treatments of sebaceous gland disorders with 5-aminolevulinic acid and photodynamic therapy are disclosed. A preferred treatment includes topical application of 5-aminolevulinic acid to the skin followed by light exposures with repeated treatment at various intervals. At low doses of ALA and photodynamic therapy (PDT) in single or multiple treatments, improvement in the sebaceous gland disorder, e.g., acne, provides the discovery that diminishment in sebum secretion and the eradication of ...


3. MX2009004874A 2009/6/16 MX20090004874 2009/5/7
专利标题:LAYERED PHARMACEUTICAL FORMULATIONS COMPRISING AN INTERMEDIATE RAPIDLY DISSOLVING LAYER. 法律状态
In one embodiment a layered pharmaceutical formulation includes two or more pharmaceutical layers and an intermediate layer disposed between at least two of the two or more pharmaceutical layers, the intermediate layer configured to dissolve in vivo to thereby leave the two or more pharmaceutical layers substantially intact. In one embodiment, an active pharmaceutical ingredient in at least one of the pharmaceutical layers is selected from bupropion, zonisamide, naltrexone, topiramate, phentermi...


4. PT1265579E 2008/9/2 PT20010916185T 2001/3/15
专利标题:CONTAINER FOR LINEZOLID INTRAVENOUS SOLUTION 法律状态
The present invention is a container for an IV aqueous solution of a Gram-positive oxazolidinone agent, such as linezolid as the compound of formula (I) which comprises having the container-solution contact surface material being a polyolefin.


5. EP1861364A1 2007/12/5 EP20060711127 2006/3/14
专利标题:PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION 法律状态


6. IE20060197A1 2006/10/18 IE20060000197 2006/3/14
专利标题:Preparation of an atorvastatin intermediate 法律状态
A process for preparing a compound of formula [1] comprises reacting 1,4-diketone of the formula [2] with a primary amine of the formula [3] wherein R1 and R2 may be the same or different and are selected from any one or more of H


7. WO2006097909A1 2006/9/21 WO2006IE00014 2006/3/14
专利标题:PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION 法律状态
A process for preparing a compound of formula (I): comprises reacting a 1,4-diketone of the formula (II): with a primary amine of the formula (III): wherein R1 and R2 may be the same or different and are selected from any one or more of H


8. CA2601111A1 2006/9/21 CA20062601111 2006/3/14
专利标题:PREPARATION OF AN ATORVASTATIN INTERMEDIATE USING A PAAL-KNORR CONDENSATION 法律状态


9. AU2001243242B2 2005/9/1 AU20010243242 2001/3/15
专利标题:Container for linezolid intravenous solution 法律状态
专利权人UPJOHN CO;


10. EA005868B1 2005/6/30 EA20020001007 2001/3/15
专利标题:CONTAINER FOR LINEZOLID INTRAVENOUS SOLUTION 法律状态
The present invention relates to a container for an intravenous solution of an oxazolidinone agent for a Gram-positive microorganisms such as oxazolidinone of formula (I): which comprises having the container-solution contact surface material being a polyolefin.



首页1234下页尾页34 条记录, 当前第1/4页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文